Sponsor Pipeline

Il-Yang Pharm. Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
5
Recruiting
3
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 3
3
Phase 2
1
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT03459534 A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure… Chronic Myeloid Leukemia, Chronic Phase Recruiting
NCT06284876 Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs… Peptic Ulcer Recruiting
NCT03722420 Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With… Chronic Myeloid Leukemia, Chronic Phase Active, Not Recruiting
Phase 2
NCT04691661 Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's… Parkinson Disease Recruiting
Phase 1
NCT07433556 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy… Healhty Recruiting
Not specified
NCT06665412 Efficacy and Safety of Dose Redution of Radotinib as a First Line Treament in Ph+ CML Chronic Phase Ph+ Chronic Myeloid Leukemia Recruiting
Disease Areas
Get alerts when Il-Yang Pharm. Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free